HOME >> MEDICINE >> NEWS
Statin drugs may lower risk of Alzheimers

DENVER, CO Taking the cholesterol-lowering drugs called statins may reduce the risk of developing Alzheimers disease, according to research presented during the American Academy of Neurologys 54th Annual Meeting in Denver, Colo., April 13-20, 2002.

The study found that taking statins was associated with a 79-percent reduction in the risk of developing Alzheimers disease, according to the studys lead author, neurologist and epidemiologist Robert C. Green, MD, MPH, of Boston University School of Medicine.

This study confirms and extends previous reports and is the largest study on this topic in the U.S., Green said. It is also the first to include a large number of African-American families.

Researchers studied 2,581 people from more than 800 families, enrolled over six years at 15 medical centers. They examined risk factors and medication history in 912 people with probable or definite Alzheimers disease and 1,669 of their family members who did not have dementia. The results were adjusted for age, sex, education, and history of heart disease, stroke and diabetes.

The relationship between statins and risk of Alzheimers was no different for people with the gene variant associated with an increased risk of Alzheimers, apolipoprotein E ?4, or apoE-?4. The relationship between statins and Alzheimers was also the same for whites as it was for African Americans, who have a higher risk of developing the disease.

Statins lower levels of low-density lipoprotein (LDL) cholesterol by blocking the production of a liver enzyme used by the body to make cholesterol. In this study, cholesterol-lowering drugs other than statins were not associated with a reduced risk of Alzheimers. There was also no difference between the use of natural and synthetic statins.


'"/>

Contact: Cheryl Alementi
calementi@aan.com
651-695-2737
American Academy of Neurology
16-Apr-2002


Page: 1

Related medicine news :

1. Statins effective in long term, Nordic study suggests
2. Statins show early promise for treating multiple sclerosis
3. Statins and aspirin may protect against severe vision loss in elderly
4. Statins could reduce stroke risk by a third
5. Statin drugs may help patients with heart valve disease avoid surgery
6. Statin drugs lower heart disease risk in postmenopausal women
7. Statin drugs may increase risk of peripheral neuropathy
8. Statins may inhibit calcium growth on aortic valve in the elderly
9. People Who Are Diabetic And Glucose Intolerant Can Benefit From "Statin" Drug Therapy, Even If Cholesterol Levels Are Normal
10. International Study Finds Statins Raise Good Cholesterol, Wake Forest Physician Reports
11. Studies Look At Threshold Effect Of Cholesterol-Lowering "Statin" Drugs

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/26/2016)... ... May 26, 2016 , ... Catalent Pharma Solutions, the ... consumer health and global clinical supply services, today announced two key appointments and ... continued investment and strategic growth plans in the Asia Pacific region. , Howard ...
(Date:5/26/2016)... ... ... Memorial Day Weekend marks the unofficial start of summer and the beginning of ... your family and vehicle are ready to hit the road this weekend. , According ... an additional 50,500 serious injuries from motor vehicle crashes during the three-day Memorial Day ...
(Date:5/26/2016)... ... , ... North Cypress Medical Center hosted its 9th Annual Spring ... the help of community partners, the event organizers raised $45,000 for the Lone ... members and their families through health, wellness, and therapeutic support. , A special ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... as an NJ Top Doc! Along with his wonderful accolades and stellar patient ... podiatry. Congratulations, Dr. Batelli! , Dr. Eugene Batelli is a highly trained ...
(Date:5/26/2016)... ... ... On May 23rd during the National Eye Institute’s “Healthy Vision Month”, Sharon ... honored by Ashram, Inc. as the world’s foremost water visionary. , “Sharon Kleyne is ... the Nile to fill their red clay pots with life-sustaining water.” Said Ashram co-founder ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... , May 25,2016 ... the near-infrared Cellvizio platform for urological and surgical ... OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary confocal ... regulatory milestone in the US with the 12 ... and Drug Administration (FDA). This new FDA clearance ...
(Date:5/25/2016)... and GERMANTOWN, Maryland , May 25, ... QGEN ; Frankfurt Prime Standard: QIA) today announced that the ... Therawis Diagnostics GmbH to develop and commercialize predictive assays in ... PITX2 as a marker to predict effectiveness of anthracycline treatment ... "We are pleased to partner with Therawis, which developed ...
(Date:5/25/2016)... May 25, 2016 According to ... Development, Growth and Demand Forecast to 2022 - Industry ... and Others)" published by P&S Market Research, the global ... in 2015, and it is expected to grow at ... the insulin pump segment is expected to witness the ...
Breaking Medicine Technology:
Cached News: